Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

FDA

BioPhotonics
Mar 2012
The first handheld device intended to aid in the detection of life-threatening bleeding in the skull has been approved for marketing by the FDA. The device, called the Infrascanner Model 1000, can help health care providers identify patients with critical head injuries who need an immediate brain imaging study. Made by InfraScan Inc. of Philadelphia, the device uses a near-IR scanner, which can nondestructively penetrate the skull through tissue and bone. Blood from the intracranial hematomas absorbs the light differently than that from other areas of the brain. The scanner detects differences in light absorption and transmits the information wirelessly to a display on a handheld computer.

AmericasBiophotonicsbleeding in the brainbrain bleedingbrain imagingbrain injurybrain injury imagingbrain injury treatmentBusinessFDAhandheld brain imagerhandheld brain imaging devicehandheld near-IR scannerhead injuriesimagingInfraScanInfrascanner Model 1000intracranial hematomasnear-infrared scannernear-IR scannerNIR scannernoninvasive brain imagerPennsylvaniaRapidScanUS Food and Drug Administration

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2017 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!